ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,333Medicare Part D Prescriptions Filled, Including Refills

Rank: 256 out of 5176

$865K Total Retail Price of All Prescriptions

Rank: 379 out of 5176

361 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 11,414 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 772 612 1 2
CRESTOR 767 592 2 15
METFORMIN HCL 706 506 3 7
OMEPRAZOLE 509 415 4 3
SIMVASTATIN 500 395 5 1
IBUPROFEN 452 327 6 72
FUROSEMIDE 398 373 7 8
GLIPIZIDE XL 334 255 8 83
MICARDIS HCT 316 240 10 9 180
ATENOLOL 296 265 10 12
NEXIUM 244 138 11 16
LOVAZA 243 157 12 43
MICARDIS 234 227 13 154
DIOVAN 216 185 14 19
METOPROLOL SUCCINATE 215 206 15 11
TAMSULOSIN HCL 202 186 16 20
MECLIZINE HCL 199 165 17 81
LOSARTAN-HYDROCHLOROTHIAZIDE 192 133 18 35
COREG CR 188 168 19 275
HYDROCHLOROTHIAZIDE 187 159 20 10
ACTOS 182 124 21 85
DIOVAN HCT 178 143 22 39
AMMONIUM LACTATE 172 161 23 91
LISINOPRIL 163 128 24 5
CLOTRIMAZOLE-BETAMETHASONE 162 128 25 94
CIPROFLOXACIN HCL 157 135 26 84
LEVOTHYROXINE SODIUM 155 123 27 4
METOPROLOL TARTRATE 154 121 28 6
DONEPEZIL HCL 138 128 29 28
ATORVASTATIN CALCIUM 137 109 30 9
ENALAPRIL MALEATE 135 111 31 22
ADVAIR DISKUS 133 78 32 32
AMITIZA 129 108 33 197
WARFARIN SODIUM 115 105 34 13
RANITIDINE HCL 114 105 35 36
GLYBURIDE 113 88 R 36 67
SINGLE USE SWAB 113 96 36 108
ALENDRONATE SODIUM 108 95 38 18
ALCOHOL SWABS 104 73 39 115
LEVEMIR FLEXPEN 103 71 40 200
CARVEDILOL 103 78 40 24
LOSARTAN POTASSIUM 102 85 42 14
ZOLPIDEM TARTRATE 101 76 43 17
SINGULAIR 101 58 43 62
PLAVIX 100 92 45 29
CLOPIDOGREL 97 94 46 26
FLUTICASONE PROPIONATE 92 62 47 38
CLONIDINE HCL 88 65 48 79
BYSTOLIC 83 77 49 96
PRAMIPEXOLE DIHYDROCHLORIDE 80 77 50 339
GLIPIZIDE ER 79 57 51 117
PIOGLITAZONE HCL 77 59 R 52 237
PRAVASTATIN SODIUM 72 71 53 23
ATENOLOL-CHLORTHALIDONE 65 65 54 161
EVISTA 65 65 54 65
NIFEDIPINE ER 65 63 54 48
NAMENDA 62 62 57 47
HYDROXYZINE HCL 62 13 R 57 213
QUINAPRIL HCL 60 60 59 82
VOLTAREN 58 51 60 97
TRAMADOL HCL 54 31 61 40
GABAPENTIN 53 50 62 21
CELEBREX 53 21 62 80
ALCOHOL PREP PADS 52 41 64 198
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 45 65 49
GLYBURIDE-METFORMIN HCL 50 46 R 65 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.